Cargando…
High Doses of Ursodeoxycholic Acid Up-Regulate the Expression of Placental Breast Cancer Resistance Protein in Patients Affected by Intrahepatic Cholestasis of Pregnancy
BACKGROUND: Ursodeoxycholic acid (UDCA) administration in intrahepatic cholestasis of pregnancy (ICP) induces bile acids (BA) efflux from the foetal compartment, but the molecular basis of this transplacental transport is only partially defined. AIM: To determine if placental breast cancer resistanc...
Autores principales: | Azzaroli, Francesco, Raspanti, Maria Elena, Simoni, Patrizia, Montagnani, Marco, Lisotti, Andrea, Cecinato, Paolo, Arena, Rosario, Simonazzi, Giuliana, Farina, Antonio, Rizzo, Nicola, Mazzella, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663799/ https://www.ncbi.nlm.nih.gov/pubmed/23717540 http://dx.doi.org/10.1371/journal.pone.0064101 |
Ejemplares similares
-
Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid
por: Joutsiniemi, Titta, et al.
Publicado: (2015) -
Ursodeoxycholic Acid and S-adenosylmethionine for the Treatment of Intrahepatic Cholestasis of Pregnancy: A Meta-analysis
por: Zhang, Yang, et al.
Publicado: (2016) -
Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a secondary analysis of the PITCHES trial
por: Fleminger, J, et al.
Publicado: (2020) -
Effect of polyene phosphatidylcholine/ursodeoxycholic acid/ademetionine on pregnancy outcomes in intrahepatic cholestasis
por: Dong, Xiao-Rui, et al.
Publicado: (2023) -
Feto-Maternal Effects of Adding Rifampicin to Ursodeoxycholic Acid in the Treatment of Intrahepatic Cholestasis of Pregnancy
por: Kumari, Anjali, et al.
Publicado: (2022)